Assay Kits_abinScience

Rafivirumab (1)

TAU pT181 (1)

Ranibizumab (3)

N/Nucleoprotein (1)

Enfortumab (1)

RBD (Beta) (1)

Obinutuzumab (2)

gG/US4 (2)

Toripalimab (1)

Cixutumumab (1)

Pasotuxizumab (1)

GP/Envelope glycoprotein (4)

Namilumab (1)

Cusatuzumab (1)

Spike Protein (Trimer) (2)

Tesidolumab (1)

Indatuximab (1)

Lintuzumab (1)

Tosatoxumab (1)

TAU pT217 (1)

Varisacumab (1)

Spike glycoprotein (RBD) (1)

Ianalumab (1)

RBD (Gamma) (1)

Afutuzumab (1)

gB/Envelope glycoprotein B (1)

Afasevikumab (1)

Dalotuzumab (1)

Rosopatamab (2)

Tirzepatide (2)

Otilimab (1)

Vorsetuzumab (1)

NP/Nucleocapsid (5)

Tanezumab (1)

Adalimumab (3)

Oleclumab (1)

Obiltoxaximab (1)

Benufutamab (1)

Crizanlizumab (1)

EPO/Erythropoietin (1)

Blosozumab (1)

RBD (E484K) (1)

Epcoritamab (1)

gE/Envelope glycoprotein E (1)

Bimekizumab (1)

Figitumumab (1)

Tarextumab (1)

Simlukafusp Alfa (1)

Milatuzumab (1)

Meplazumab (1)

Rituximab (1)

Natalizumab (2)

Certolizumab (2)

Zampilimab (1)

Gremubamab (1)

Conatumumab (1)

Inclacumab (1)

Romosozumab (1)

RBD (Kappa) (1)

Glofitamab (1)

gD/Envelope glycoprotein D (1)

Ixekizumab (1)

Ganitumab (1)

Urelumab (1)

IL6 (1)

Disitamab (1)

Alacizumab (1)

Ramucirumab (1)

Romiplostim (2)

Golimumab (2)

Vofatamab (1)

M1R (5)

Drozitumab (1)

Olaratumab (1)

Mirikizumab (2)

RBD (Delta Plus) (1)

Ibritumomab (1)

gC/Envelope glycoprotein C (1)

Remtolumab (1)

Teprotumumab (1)

Utomilumab (1)

Aflibercept (1)

Pertuzumab (3)

Ascrinvacumab (1)

Sotrovimab (1)

Infliximab (2)

Oxelumab (1)

H3L (3)

Lexatumumab (1)

Tovetumab (1)

Dilpacimab (1)

RBD (Delta) (3)

Mosunetuzumab (1)

gC/UL44 (1)

Secukinumab (2)

Apamistamab (1)

Magrolimab (1)

sCD14 (1)

Trastuzumab (2)

Zanidatamab (1)

Cinpanemab (1)

Casirivimab (1)

Canakinumab (1)

Dupilumab (3)

E8L (5)

Tigatuzumab (1)

Ipilimumab (2)

Navicixizumab (1)

A29L (6)

Ocaratuzumab (1)

gD/US6 (1)

Tibulizumab (1)

Emibetuzumab (1)

Sibrotuzumab (1)

Zenocutuzumab (1)

CD79B (2)

Imdevimab (1)

Gevokizumab (1)

Iscalimab (1)

A35R (5)

Faricimab (1)

Tremelimumab (1)

Atezolizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Carlumab (1)

US8/gE (1)

Vunakizumab (1)

Tocilizumab (3)

Amatuximab (1)

Anetumab (1)

Clazakizumab (1)

Ivuxolimab (1)

F/Fusion glycoprotein F0 (5)

Basiliximab (1)

Varlilumab (1)

Eculizumab (3)

Nesvacumab (1)

Zalifrelimab (1)

Avelumab (3)

NP/Nucleoprotein (3)

Lorvotuzumab (1)

Spike glycoprotein E2 (2)

Tiragolumab (2)

Lacnotuzumab (1)

Sacituzumab (1)

RBD (Omicron/BA.4/BA.5) (1)

Ontamalimab (1)

Olokizumab (1)

Pogalizumab (1)

Guselkumab (2)

Camidanlumab (1)

Talacotuzumab (1)

Denosumab (3)

Vanucizumab (1)

Edrecolomab (1)

Durvalumab (3)

IL1RL1/ST2 (1)

Tisotumab (1)

Spike glycoprotein E1 (2)

Enoblituzumab (1)

Semorinemab (1)

Semaglutide (1)

Glembatumumab (1)

Sirukumab (1)

Tavolimab (1)

Elotuzumab (1)

Daclizumab (1)

Vibecotamab (1)

Cetuximab (3)

Lupartumab (1)

Rolinsatamab (1)

Pacmilimab (1)

cAMP (1)

Imalumab (1)

dsRNA (1)

Mirzotamab (1)

Omburtamab (1)

Tilavonemab (1)

B6R/SL-159 (1)

Balstilimab (1)

Ziltivekimab (1)

Lirilumab (1)

Evolocumab (1)

Ibalizumab (1)

Bimagrumab (1)

Sarilumab (2)

Depatuxizumab (1)

Anifrolumab (1)

Nirsevimab (1)

cGMP (1)

Andecaliximab (1)

ATP7B (1)

Frovocimab (1)

Nivolumab (5)

Zagotenemab (1)

RBD (Omicron/JN.1) (1)

Cetrelimab (1)

Cergutuzumab (1)

Codrituzumab (1)

Alirocumab (1)

Tregalizumab (1)

Daratumumab (3)

Ustekinumab (3)

Losatuxizumab (1)

Icrucumab (1)

Palivizumab (3)

BSA (1)

Farletuzumab (1)

TPP15 (1)

Mirvetuximab (1)

TPP17 (1)

Lodelcizumab (1)

Etanercept (3)

Befovacimab (1)

RBD (Omicron/KP.2) (1)

Pembrolizumab (3)

Labetuzumab (1)

Astegolimab (1)

RBD (Omicron/BA.5) (3)

Zanolimumab (1)

Ifabotuzumab (1)

Omalizumab (2)

Necitumumab (1)

Ieramilimab (1)

Suptavumab (1)

Protein A (1)

Bevacizumab (3)

TPP47 (1)

Tezepelumab (1)

RBD (WT) (1)

Concizumab (1)

CD340/ERBB2 (1)

Sintilimab (1)

Cabiralizumab (1)

Belantamab (1)

dsDNA (1)

Eldelumab (1)

Letolizumab (1)

RBD (6)

Panitumumab (3)

Mavezelimab (1)

Suvizumab (1)

Human β Amyloid (1-42) (1)

Foravirumab (1)

Human β Amyloid (1-40) (1)

Brolucizumab (1)

G/Major surface glycoprotein G (1)

Elezanumab (1)

RBD (Alpha) (1)

Marstacimab (1)

M/Matrix protein (2)

Tislelizumab (1)

Emactuzumab (1)

Teclistamab (1)

Glycoprotein (5)

Lenzilumab (1)

Itolizumab (1)

Spike glycoprotein (10)

Serclutamab (1)

Favezelimab (1)

Recombinant Proteins

Antibodies

Assay Kits

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Quick access

Contact Us